<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Green tea <z:chebi fb="0" ids="26195">polyphenol</z:chebi> <z:chebi fb="0" ids="42255">(-)-epigallocatechin</z:chebi> <z:chebi fb="0" ids="16918">gallate</z:chebi> (<z:chebi fb="0" ids="4806">EGCG</z:chebi>) has been reported to reduce neuronal damage after cerebral ischemic insult </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="0" ids="4806">EGCG</z:chebi> is known to reduce matrix metalloproteinase (MMP) activity </plain></SENT>
<SENT sid="2" pm="."><plain>MMP can play an important role in the pathophysiology of <z:e sem="disease" ids="C1112108" disease_type="Disease or Syndrome" abbrv="">neurological disorders</z:e> including <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The purpose of the current study was to investigate whether <z:chebi fb="0" ids="4806">EGCG</z:chebi> shows an inhibitory effect on MMP activity and neural tissue damage following transient focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>In the present study, C57BL/6 mice were subjected to 80 min of focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> induced by middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) </plain></SENT>
<SENT sid="5" pm="."><plain>Animals were killed 24 h after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="0" ids="4806">EGCG</z:chebi> (50 mg/kg) was administered intraperitoneally immediately after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Gelatin gel zymography showed an increase in the active form of MMP-9 after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="0" ids="4806">EGCG</z:chebi> reduced <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced up-regulation of the active form of MMP-9 </plain></SENT>
<SENT sid="9" pm="."><plain>In in situ zymography, <z:chebi fb="0" ids="4806">EGCG</z:chebi> reduced up-regulation of gelatinase activity induced by <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>Co-incubation with <z:chebi fb="0" ids="4806">EGCG</z:chebi> reduced gelatinase activity directly in postischemic brain section </plain></SENT>
<SENT sid="11" pm="."><plain>In 2,3,5-triphenyltetrazolium <z:chebi fb="76" ids="17996">chloride</z:chebi> (TTC) assay, <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> was remarkable in the middle cerebral artery territory after focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>In <z:chebi fb="0" ids="4806">EGCG</z:chebi>-treated mice, <z:mpath ids='MPATH_124'>infarct</z:mpath> volume was significantly reduced compared with vehicle-treated mice </plain></SENT>
<SENT sid="13" pm="."><plain>These results demonstrate that <z:chebi fb="0" ids="4806">EGCG</z:chebi>, a green tea <z:chebi fb="0" ids="26195">polyphenol</z:chebi>, may reduce up-regulation of MMP-9 activity and neuronal damage following transient focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="14" pm="."><plain>In addition to its <z:chebi fb="11" ids="22586">antioxidant</z:chebi> effect, MMP-9 inhibition might be a possible mechanism potentially involved in the neuroprotective effect of a green tea <z:chebi fb="0" ids="26195">polyphenol</z:chebi>, <z:chebi fb="0" ids="4806">EGCG</z:chebi> </plain></SENT>
</text></document>